Dare Bioscience, Inc. Depreciation
Dare Bioscience, Inc. (DARE) reported Depreciation of $162.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-03-26
- Dare Bioscience, Inc. depreciation for the quarter ending 2024-12-31 was $6.04K, a 39.45% decline year-over-year.
- Dare Bioscience, Inc. depreciation for the quarter ending 2024-09-30 was $9.74K, a 5.21% increase year-over-year.
- Dare Bioscience, Inc. depreciation for the quarter ending 2024-06-30 was $15.44K, a 60.55% increase year-over-year.
- Dare Bioscience, Inc. depreciation for the quarter ending 2024-03-31 was $10.78K, a 13.36% increase year-over-year.
- Dare Bioscience, Inc. depreciation for fiscal 2025 was $162.00K, a 285.71% increase from fiscal 2024.
- Dare Bioscience, Inc. depreciation for fiscal 2024 was $42.00K, a 9.48% increase from fiscal 2023.
- Dare Bioscience, Inc. depreciation for fiscal 2023 was $38.36K, a 58.51% increase from fiscal 2022.
- Dare Bioscience, Inc. depreciation for fiscal 2022 was $24.20K, a 8.37% decline from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $162.00K 10-K · filed 2026-03-26 | ||||
| 2024-12-31 | $6.04K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $15.79K derived: sum of 2 quarters · filed 2026-03-26 | $31.22K derived: sum of 3 quarters · filed 2026-03-26 | $42.00K 10-K · filed 2026-03-26 | $42.33K 10-K · filed 2025-03-31 |
| 2024-09-30 | $9.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $25.18K derived: sum of 2 quarters · filed 2024-11-14 | $35.96K 10-Q · filed 2024-11-14 | $45.94K derived: sum of 4 quarters · filed 2025-03-31 | |
| 2024-06-30 | $15.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $26.21K 10-Q · filed 2024-08-12 | $36.20K derived: sum of 3 quarters · filed 2025-03-31 | $45.45K derived: sum of 4 quarters · filed 2025-03-31 | |
| 2024-03-31 | $10.78K 10-Q · filed 2024-05-14 | $20.76K derived: sum of 2 quarters · filed 2025-03-31 | $30.02K derived: sum of 3 quarters · filed 2025-03-31 | $39.63K derived: sum of 4 quarters · filed 2025-03-31 | |
| 2023-12-31 | $9.98K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $19.24K derived: sum of 2 quarters · filed 2025-03-31 | $28.86K derived: sum of 3 quarters · filed 2025-03-31 | $38.36K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $9.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $18.88K derived: sum of 2 quarters · filed 2024-11-14 | $28.38K 10-Q · filed 2024-11-14 | $39.01K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $9.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $19.12K 10-Q · filed 2024-08-12 | $29.75K derived: sum of 3 quarters · filed 2024-08-12 | $32.78K derived: sum of 4 quarters · filed 2024-08-12 | |
| 2023-03-31 | $9.51K 10-Q · filed 2024-05-14 | $20.13K derived: sum of 2 quarters · filed 2024-05-14 | $23.16K derived: sum of 3 quarters · filed 2024-05-14 | $28.48K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $10.62K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $13.66K derived: sum of 2 quarters · filed 2024-03-28 | $18.98K derived: sum of 3 quarters · filed 2024-03-28 | $24.20K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $3.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $8.35K derived: sum of 2 quarters · filed 2023-11-09 | $13.58K 10-Q · filed 2023-11-09 | $20.63K derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $5.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $10.55K 10-Q · filed 2023-08-10 | $17.59K derived: sum of 3 quarters · filed 2023-08-10 | $23.94K derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | $5.23K 10-Q · filed 2023-05-11 | $12.27K derived: sum of 2 quarters · filed 2023-05-11 | $18.62K derived: sum of 3 quarters · filed 2023-05-11 | $25.23K derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $7.05K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $13.39K derived: sum of 2 quarters · filed 2023-03-30 | $20.00K derived: sum of 3 quarters · filed 2023-03-30 | $26.41K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $6.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $12.96K derived: sum of 2 quarters · filed 2022-11-10 | $19.37K 10-Q · filed 2022-11-10 | $26.16K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $6.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $13.02K 10-Q · filed 2022-08-09 | $19.82K derived: sum of 3 quarters · filed 2022-08-09 | $32.32K derived: sum of 4 quarters · filed 2022-08-09 | |
| 2021-03-31 | $6.41K 10-Q · filed 2022-05-12 | $13.21K derived: sum of 2 quarters · filed 2022-05-12 | $25.71K derived: sum of 3 quarters · filed 2022-05-12 | $37.69K derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $6.80K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $19.30K derived: sum of 2 quarters · filed 2022-03-31 | $31.28K derived: sum of 3 quarters · filed 2022-03-31 | $43.23K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $12.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $24.48K derived: sum of 2 quarters · filed 2021-11-10 | $36.43K 10-Q · filed 2021-11-10 | $44.07K derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $11.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $23.93K 10-Q · filed 2021-08-12 | $31.57K derived: sum of 3 quarters · filed 2021-08-12 | $32.75K derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $11.95K 10-Q · filed 2021-05-13 | $19.59K derived: sum of 2 quarters · filed 2021-05-13 | $20.77K derived: sum of 3 quarters · filed 2021-05-13 | $21.94K derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | $7.65K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $8.82K derived: sum of 2 quarters · filed 2021-03-30 | $9.99K derived: sum of 3 quarters · filed 2021-03-30 | $11.14K 10-K · filed 2021-03-30 | |
| 2019-09-30 | $1.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $2.34K derived: sum of 2 quarters · filed 2020-11-12 | $3.49K 10-Q · filed 2020-11-12 | $4.67K derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | $1.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $2.31K 10-Q · filed 2020-08-12 | $3.49K derived: sum of 3 quarters · filed 2020-08-12 | $4.47K derived: sum of 4 quarters · filed 2020-08-12 | |
| 2019-03-31 | $1.15K 10-Q · filed 2020-05-14 | $2.33K derived: sum of 2 quarters · filed 2020-05-14 | $3.30K derived: sum of 3 quarters · filed 2020-05-14 | $3.59K derived: sum of 4 quarters · filed 2020-05-14 | |
| 2018-12-31 | $1.18K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $2.15K derived: sum of 2 quarters · filed 2020-03-27 | $2.44K derived: sum of 3 quarters · filed 2020-03-27 | $2.44K 10-K · filed 2020-03-27 | |
| 2018-09-30 | $975.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $1.26K derived: sum of 2 quarters · filed 2019-11-12 | $1.26K 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $288.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $288.00 10-Q · filed 2019-08-14 | |||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-14 | ||||
| 2017-12-31 | $0.00 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |